Tweet
Ingevity Corp (NYSE:NGVT) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 1,101,119 shares, an increase of 74.5% from the July 13th total of 630,876 shares. Based on an average trading volume of 357,784 shares, the days-to-cover ratio is currently 3.1 days. Currently, 2.6% of the company's shares are short sold.
A number of analysts have recently commented on the company. KeyCorp upped their price target on Ingevity from $89.00 to $90.00 and gave the company an "overweight" rating in a research note on Friday, May 4th. Berenberg Bank assumed coverage on Ingevity in a research note on Thursday, July 12th. They issued a "buy" rating and a $100.00 price target for the company. Oppenheimer reaffirmed a "buy" rating on shares of Ingevity in a research note on Wednesday, May 9th. TheStreet raised Ingevity from a "c" rating to a "b-" rating in a research note on Monday, April 30th. Finally, Zacks Investment Research raised Ingevity from a "hold" rating to a "buy" rating and set a $111.00 price target for the company in a research note on Monday, July 30th. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The stock currently has a consensus rating of "Buy" and an average target price of $100.33. Get Ingevity alerts:
Shares of NGVT opened at $97.80 on Friday. The company has a debt-to-equity ratio of 2.09, a current ratio of 2.58 and a quick ratio of 1.48. Ingevity has a 52-week low of $55.07 and a 52-week high of $101.67. The company has a market capitalization of $4.21 billion, a P/E ratio of 37.91, a price-to-earnings-growth ratio of 2.28 and a beta of 1.30. Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, July 25th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.99 by $0.13. Ingevity had a return on equity of 46.65% and a net margin of 14.72%. The business had revenue of $308.60 million during the quarter, compared to analyst estimates of $305.14 million. During the same period in the previous year, the firm earned $0.78 EPS. Ingevity's quarterly revenue was up 18.6% compared to the same quarter last year. equities analysts forecast that Ingevity will post 3.66 EPS for the current year.
Institutional investors and hedge funds have recently modified their holdings of the stock. Federated Investors Inc. PA grew its position in shares of Ingevity by 2.1% in the 1st quarter. Federated Investors Inc. PA now owns 424,510 shares of the company's stock valued at $31,282,000 after purchasing an additional 8,910 shares during the period. Schwab Charles Investment Management Inc. boosted its position in Ingevity by 3.6% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 270,000 shares of the company's stock worth $19,897,000 after acquiring an additional 9,443 shares during the last quarter. OppenheimerFunds Inc. boosted its position in Ingevity by 8.2% during the 1st quarter. OppenheimerFunds Inc. now owns 417,637 shares of the company's stock worth $30,776,000 after acquiring an additional 31,642 shares during the last quarter. Foundry Partners LLC boosted its position in Ingevity by 16.5% during the 1st quarter. Foundry Partners LLC now owns 33,363 shares of the company's stock worth $2,459,000 after acquiring an additional 4,731 shares during the last quarter. Finally, EFG Asset Management Americas Corp. acquired a new position in Ingevity during the 2nd quarter worth approximately $2,056,000. Institutional investors and hedge funds own 89.44% of the company's stock.
About Ingevity
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems